Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer

AIM: To directly compare the efficacy and toxicity of standard-dose FOLFIRINOX (sFOLFIRINOX) and modified-dose FOLFIRINOX (mFOLFIRINOX, 75% of standard-dose) for pancreatic cancer. METHODS: One hundred and thirty pancreatic cancer patients who received sFOLFIRINOX (n = 88) or mFOLFIRINOX (n = 42) as...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastrointest Oncol
Auteurs principaux: Kang, Huapyong, Jo, Jung Hyun, Lee, Hee Seung, Chung, Moon Jae, Bang, Seungmin, Park, Seung Woo, Song, Si Young, Park, Jeong Youp
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2018
Sujets:
Retrospective Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247105/
https://ncbi.nlm.nih.gov/pubmed/30487953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v10.i11.421
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires